Key points are not available for this paper at this time.
Impella 2.5 (pLVAD) support protected against AKI during high-risk PCI. This renal protective effect persisted despite the presence of underlying CKD and decreasing ejection fraction.
Flaherty et al. (Wed,) studied this question.